Logo image of AXS.AS

ACCSYS TECHNOLOGIES PLC (AXS.AS) Stock Fundamental Analysis

AMS:AXS - Euronext Amsterdam - GB00BQQFX454 - Common Stock - Currency: EUR

0.53  0 (-0.36%)

Fundamental Rating

3

Taking everything into account, AXS scores 3 out of 10 in our fundamental rating. AXS was compared to 11 industry peers in the Paper & Forest Products industry. The financial health of AXS is average, but there are quite some concerns on its profitability. AXS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year AXS has reported negative net income.
In the past year AXS had a positive cash flow from operations.
In multiple years AXS reported negative net income over the last 5 years.
Each year in the past 5 years AXS had a positive operating cash flow.
AXS.AS Yearly Net Income VS EBIT VS OCF VS FCFAXS.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

AXS has a Return On Assets of -16.92%. This is in the lower half of the industry: AXS underperforms 63.64% of its industry peers.
The Return On Equity of AXS (-35.12%) is worse than 63.64% of its industry peers.
AXS has a Return On Invested Capital (2.34%) which is in line with its industry peers.
Industry RankSector Rank
ROA -16.92%
ROE -35.12%
ROIC 2.34%
ROA(3y)-8.3%
ROA(5y)-4.7%
ROE(3y)-15.07%
ROE(5y)-8.42%
ROIC(3y)N/A
ROIC(5y)N/A
AXS.AS Yearly ROA, ROE, ROICAXS.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

The Operating Margin of AXS (3.50%) is comparable to the rest of the industry.
AXS has a Gross Margin (31.12%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of AXS has grown nicely.
Industry RankSector Rank
OM 3.5%
PM (TTM) N/A
GM 31.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y3.9%
AXS.AS Yearly Profit, Operating, Gross MarginsAXS.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AXS is destroying value.
The number of shares outstanding for AXS has been increased compared to 1 year ago.
Compared to 5 years ago, AXS has more shares outstanding
The debt/assets ratio for AXS has been reduced compared to a year ago.
AXS.AS Yearly Shares OutstandingAXS.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AXS.AS Yearly Total Debt VS Total AssetsAXS.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.46, we must say that AXS is in the distress zone and has some risk of bankruptcy.
AXS has a worse Altman-Z score (0.46) than 63.64% of its industry peers.
The Debt to FCF ratio of AXS is 4.92, which is a neutral value as it means it would take AXS, 4.92 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.92, AXS is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
A Debt/Equity ratio of 0.70 indicates that AXS is somewhat dependend on debt financing.
AXS has a better Debt to Equity ratio (0.70) than 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 4.92
Altman-Z 0.46
ROIC/WACC0.33
WACC7.14%
AXS.AS Yearly LT Debt VS Equity VS FCFAXS.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

AXS has a Current Ratio of 2.03. This indicates that AXS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.03, AXS belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
AXS has a Quick Ratio of 1.34. This is a normal value and indicates that AXS is financially healthy and should not expect problems in meeting its short term obligations.
AXS has a better Quick ratio (1.34) than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.34
AXS.AS Yearly Current Assets VS Current LiabilitesAXS.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

AXS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.05%.
The Revenue for AXS has decreased by -21.31% in the past year. This is quite bad
AXS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.62% yearly.
EPS 1Y (TTM)-12.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.89%
Revenue 1Y (TTM)-21.31%
Revenue growth 3Y10.91%
Revenue growth 5Y12.62%
Sales Q2Q%1.42%

3.2 Future

AXS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.49% yearly.
The Revenue is expected to grow by 4.61% on average over the next years.
EPS Next Y-212.93%
EPS Next 2Y48.71%
EPS Next 3Y43.49%
EPS Next 5YN/A
Revenue Next Year-2.54%
Revenue Next 2Y2.78%
Revenue Next 3Y6.17%
Revenue Next 5Y4.61%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AXS.AS Yearly Revenue VS EstimatesAXS.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
AXS.AS Yearly EPS VS EstimatesAXS.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 0 -0.05 -0.1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AXS. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 66.40, which means the current valuation is very expensive for AXS.
The rest of the industry has a similar Price/Forward Earnings ratio as AXS.
When comparing the Price/Forward Earnings ratio of AXS to the average of the S&P500 Index (20.49), we can say AXS is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 66.4
AXS.AS Price Earnings VS Forward Price EarningsAXS.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AXS is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, AXS is valued a bit cheaper than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.48
EV/EBITDA 11.8
AXS.AS Per share dataAXS.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

AXS's earnings are expected to grow with 43.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.71%
EPS Next 3Y43.49%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AXS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACCSYS TECHNOLOGIES PLC

AMS:AXS (5/2/2025, 1:01:41 PM)

0.53

0 (-0.36%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)11-26 2024-11-26
Earnings (Next)06-24 2025-06-24/amc
Inst Owners39.62%
Inst Owner ChangeN/A
Ins Owners0.57%
Ins Owner ChangeN/A
Market Cap127.42M
Analysts85.45
Price Target0.98 (84.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.6%
PT rev (3m)0.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-32.92%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 66.4
P/S 0.93
P/FCF 9.48
P/OCF 8.34
P/B 1.4
P/tB 1.52
EV/EBITDA 11.8
EPS(TTM)-0.13
EYN/A
EPS(NY)0.01
Fwd EY1.51%
FCF(TTM)0.06
FCFY10.55%
OCF(TTM)0.06
OCFY12%
SpS0.57
BVpS0.38
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.92%
ROE -35.12%
ROCE 3.12%
ROIC 2.34%
ROICexc 2.82%
ROICexgc 2.97%
OM 3.5%
PM (TTM) N/A
GM 31.12%
FCFM 9.8%
ROA(3y)-8.3%
ROA(5y)-4.7%
ROE(3y)-15.07%
ROE(5y)-8.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y3.9%
F-Score3
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 4.92
Debt/EBITDA 4.43
Cap/Depr 19.53%
Cap/Sales 1.34%
Interest Coverage 2.15
Cash Conversion 107.28%
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 1.34
Altman-Z 0.46
F-Score3
WACC7.14%
ROIC/WACC0.33
Cap/Depr(3y)378.65%
Cap/Depr(5y)352.01%
Cap/Sales(3y)19.57%
Cap/Sales(5y)19.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.89%
EPS Next Y-212.93%
EPS Next 2Y48.71%
EPS Next 3Y43.49%
EPS Next 5YN/A
Revenue 1Y (TTM)-21.31%
Revenue growth 3Y10.91%
Revenue growth 5Y12.62%
Sales Q2Q%1.42%
Revenue Next Year-2.54%
Revenue Next 2Y2.78%
Revenue Next 3Y6.17%
Revenue Next 5Y4.61%
EBIT growth 1Y-59.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year228.71%
EBIT Next 3Y72.49%
EBIT Next 5YN/A
FCF growth 1Y126.36%
FCF growth 3Y-22.01%
FCF growth 5YN/A
OCF growth 1Y3050.58%
OCF growth 3Y-29.11%
OCF growth 5Y88.8%